Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

13,025 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A systematic review of the safety of topical therapies for atopic dermatitis.
Callen J, Chamlin S, Eichenfield LF, Ellis C, Girardi M, Goldfarb M, Hanifin J, Lee P, Margolis D, Paller AS, Piacquadio D, Peterson W, Kaulback K, Fennerty M, Wintroub BU. Callen J, et al. Among authors: lee p. Br J Dermatol. 2007 Feb;156(2):203-21. doi: 10.1111/j.1365-2133.2006.07538.x. Br J Dermatol. 2007. PMID: 17223859 Free article. Review.
Spesolimab, an anti-interleukin-36 receptor antibody, in patients with moderate-to-severe atopic dermatitis: Results from a multicentre, randomized, double-blind, placebo-controlled, phase IIa study.
Bissonnette R, Abramovits W, Saint-Cyr Proulx É, Lee P, Guttman-Yassky E, Zovko E, Sigmund R, Willcox J, Bieber T. Bissonnette R, et al. Among authors: lee p. J Eur Acad Dermatol Venereol. 2023 Mar;37(3):549-557. doi: 10.1111/jdv.18727. Epub 2023 Jan 4. J Eur Acad Dermatol Venereol. 2023. PMID: 36376738 Clinical Trial.
Level of education and the risk of malignant melanoma.
Lee PY, Silverman MK, Rigel DS, Vossaert KA, Kopf AW, Bart RS, Garfinkel L, Levenstein MJ. Lee PY, et al. J Am Acad Dermatol. 1992 Jan;26(1):59-63. doi: 10.1016/0190-9622(92)70007-3. J Am Acad Dermatol. 1992. PMID: 1732337 Free article.
Hidradenoma Papilliferum: Everyone Else's Diagnosis.
Patel S, Lambert WC, Behbanani S, Espinal-Mariotte JD, Lee P. Patel S, et al. Among authors: lee p. Indian J Dermatol. 2020 Mar-Apr;65(2):151-153. doi: 10.4103/ijd.IJD_256_18. Indian J Dermatol. 2020. PMID: 32180606 Free PMC article.
Efficacy and safety of tildrakizumab 100 mg for plaque psoriasis in patients randomized to treatment continuation vs treatment withdrawal with retreatment upon relapse in reSURFACE 1.
Cantrell W, Lee P, Mendelsohn AM, Rozzo SJ, Liao W. Cantrell W, et al. Among authors: lee p. J Eur Acad Dermatol Venereol. 2021 Aug;35(8):e526-e528. doi: 10.1111/jdv.17124. Epub 2021 Feb 12. J Eur Acad Dermatol Venereol. 2021. PMID: 33460505 Free PMC article. Clinical Trial. No abstract available.
Efficacy of tildrakizumab by patient demographic and disease characteristics across a phase 2b and 2 phase 3 trials in patients with moderate-to-severe chronic plaque psoriasis.
Poulin Y, Ramon M, Rosoph L, Weisman J, Mendelsohn AM, Parno J, Rozzo SJ, Lee P. Poulin Y, et al. Among authors: lee p. J Eur Acad Dermatol Venereol. 2020 Jul;34(7):1500-1509. doi: 10.1111/jdv.16187. Epub 2020 Feb 9. J Eur Acad Dermatol Venereol. 2020. PMID: 31919889 Clinical Trial.
13,025 results
You have reached the last available page of results. Please see the User Guide for more information.